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Abstract  
The striking correlation between advanced age and an increased incidence of 
cancer has led investigators to examine the influence of aging on genome maintenance. 
Because loss of heterozygosity (LOH) can lead to the inactivation of tumor suppressor 
genes, and thus carcinogenesis, understanding the affect of aging on this type of mutation 
event is particularly important. Several factors may affect the rate of LOH, including an 
increase in the amount of DNA damage, specifically double-strand breaks (DSB), and the 
ability to efficiently repair this damage via pathways that minimize the loss of genetic 
information.  Because of experimental constraints, there is only suggestive evidence for a 
change in the rate of DNA damage as humans age.  However, recent studies in model 
organisms find that there are increased rates of LOH with age, and that repair of DNA 
damage occurs via a different pathway in old cells versus young cells.  We speculate that 
the age-dependent change in DNA repair may explain why there is increased LOH, and 
that the findings from these model organisms may extend to humans.  
1.  Introduction 
Age is the greatest carcinogen – as a person enters middle-age they begin a period 
in which there is an exponential increase in the incidence of many types of cancer with 
each additional year (DePinho, 2000). The precise mechanism underlying the dramatic 
age-related rise of cancer remains unclear, but the importance of mutation in cancer 
presents a likely explanation (Knudson, 2001). It is hypothesized that a small number of 
genetic events — causing either activation of oncogenes or inactivation of tumor 
suppressor genes — precede each stage of tumorigenesis (Armitage, 1954; Armitage, 
1957; Knudson, 2001). By middle age, sufficient cellular genomic damage may have 
accumulated to initiate carcinogenesis. 
However, based on the rates of spontaneous mutation observed in human tissue 
2 
culture cells, the steady accumulation of mutations cannot account for the amount of 
genetic changes that are present in most tumors (Lengauer et al., 1998). This has led to 
the hypothesis that one of the early steps in cancer progression is a genetic change 
causing a switch to a higher than normal rate of mutation, creating a ‘mutator phenotype’ 
that increases the likelihood of subsequent genetic events (Loeb, 1991)(Loeb and Loeb, 
2003)(Nowak et al., 2002).  The relationship between advanced age and the incidence of 
cancer also raises the question: does aging lead to a higher than normal rate of mutation?  
If so, is there a specific alteration in genome maintenance responsible for this change?  
Or is it simply the affect of accumulated mutations at a constant rate over time?  To 
address these questions, we will discuss the affect of aging on loss of heterozygosity, a 
genetic change that has a significant impact on a cell’s normal function. 
Loss of heterozygosity 
In considering events that may lead to oncogenesis, tumor suppressors have had a major 
impact on the thinking, leading to a focus on identifying mechanisms that result in loss of 
gene function (Brown, 1997).  This is particularly relevant in the context of 
heterozygosity, where one functional dominant allele is “covering” the phenotype of a 
defective recessive allele. Loss of normal allele function could occur by any number of 
means, including point mutation, recombination (that “convert” the normal copy to the 
mutant version), or gene deletion (see Figure 1). The importance of this paradigm 
emerged in the 1980’s during studies of tumorigenesis in patients that had a 
predisposition to retinoblastoma (Cavenee et al., 1983). Patients who were heterozygous 
at the Rb locus, with one wild-type allele and one non-functional allele in the Rb gene, 
had a high incidence of tumors that had “lost” the wild type allele of Rb in somatic cells. 
As noted above, there are several mechanisms by which the normal allele of Rb could 
become non-functional.  However the predominant pathways for loss occurred by 
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deletion of the wild-type allele due to loss of an entire chromosome or a portion of it (a 
hemizygous state), or via a recombination event that replaced the wild-type allele with 
the non-functional, mutant allele from the homologous chromosome (a homozygous 
state). Consequently, these genetic changes became known as “loss of heterozygosity” 
(LOH) events. [Due to limits of methods at the time, point mutations, small deletions, 
short gene conversions, and epigenetic changes could not be detected. These events are 
not loss of heterozygosity in the true sense of the word. However, they are frequently 
classified as LOH events.]  Clearly, LOH is not the only mechanism of genomic 
instability leading to carcinogenesis, however due to its direct link to tumor development 
and progression, it is important to understand how LOH is affected by aging.  
LOH can arise as the result of chromosome mis-segregation, or a cell’s attempt 
(or inability) to repair DNA damage in the form of a double-strand break (DSB).  Cells 
are equipped with an array of DNA repair pathways to handle such damage (Paques and 
Haber, 1999). However in some cases the repair results in changes of the genome, which 
can manifest as LOH.  The relationship between aging and LOH may be considered as 
two sides of a coin: Does LOH (and genomic instability in general) lead to aging, and/or 
does aging lead to LOH?  In this mini-review we will examine whether LOH changes as 
a function of age, evaluating evidence (from a representative set of data) for changes in 
the rate of LOH and the means by which it occurs. 
2.  Is there an increased rate of LOH with age? 
Due to the striking correlation between advanced age and the incidence of cancer, 
it has long been thought that the rate of DNA damage and subsequent mutations must 
increase as an organism ages (Loeb, 1991) Although it is easy to speculate about sources 
of increased endogenous damage, including oxidative stress, telomere dysfunction, an 
increase in collapsed replication forks, etc. (DePinho, 2000)(Finkel and Holbrook, 
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2000)(Lombard et al., 2005), it is difficult to actually determine whether there is an 
increased rate (the number of events per unit time, or per cell division) of mutation in old 
compared to young individuals.  To accurately measure rate of LOH, it is necessary to 
assay for a mutation with each cell division.  Due to this experimental constraint, many 
studies analyzing changes in genome stability with age are only able to provide 
information on the changes in mutation frequency – which is missing the important 
component of time.  
The Experimental Data 
Early studies performed by P. Stambrook and J. Tischfield, used a novel assay for 
LOH in human T-lymphocytes from individuals heterozygous for a non-functional 
adenine phosphoribosyltranferase gene (APRT) (Gupta et al., 1997).  These studies 
demonstrated LOH in somatic cells, predominately due to mitotic recombination.  
Building on this work, several investigators have measured the frequency of LOH in 
young cells and contrasted this to the frequency seen in old cells.  For instance, mice 
heterozygous for the Aprt gene (Aprt+/-) were studied for loss-of-function mutations.  
Cells that undergo LOH at this locus (Aprt -/-) become resistant to toxic purine analogs 
such as 8-aza-adenine (8AA).  Spontaneous in vivo events were measured by isolating 
cells from these mice and expanding the cell population in vitro in the presence of 8AA.  
In one such study, lymphocytes from young heterozygous mice had a loss-of-function, 
mutant frequency of 8.7 x 10 –6 (Van Sloun et al., 1998).  Further analysis with allele 
specific PCR demonstrated 70% of these mutants had lost the wild-type allele.  When 
similar studies were performed on mice older than one year, the mutant frequency had 
increased by ten-fold, with 90% of the mutants demonstrating LOH (Wijnhoven et al., 
2001). These results are consistent with a more recent study that measured the frequency 
of mitotic recombination in pancreatic cells of adult mice with an integrated fluorescent 
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reporter (Wiktor-Brown et al., 2006).  When cells from mice of increased age (67-74 
weeks) were examined, the median frequency of cells that had undergone mitotic 
recombination within the pancreatic tissue had increased as contrasted to young mice (4 
weeks).  Furthermore, an increase in the frequency of LOH was detected in the progeny 
of murine neural stem/progenitor cells from mice two months old vs. those two years old 
(Bailey et al., 2004). 
In a study with human subjects, changes in mutant frequency with age were 
examined in lymphocytes.  Mutant cells in this assay were identified by alterations in the 
HLA-A locus using antibody-complement immunoselection (Morley et al., 1990). 
Results showed that the total number of mutant lymphocytes increased significantly with 
age.  The geometric mean frequency increased from 0.71x10-5 in neonates to 6.53x10-5 in 
the elderly (Grist et al., 1992).  Similarly, stable chromosome aberrations that increased 
in frequency with increasing age were observed in human peripheral lymphocytes 
(Vorobtsova et al., 2001). All these studies demonstrate an accumulation of cells that 
have undergone loss-of-function mutations and/or LOH in mammals of advanced age. 
Unresolved Issues 
 Although these studies show increases in LOH with age, and provide intriguing 
observations for further investigation, they are of limited value because they all presented 
their data as mutant frequencies.  In contrast to a mutation rate, a mutation frequency is 
limited in terms of the conclusions that can be made, which is especially relevant to our 
discussion of changes with age (reviewed in Rosche and Foster, 2000). As a cell grows 
and divides it has a low but nonzero probability to sustain a mutation during its lifetime, 
and this probability is its mutation rate. After a cell sustains a mutation it can produce a 
clone of mutants, and the size of this clone will depend upon when in the growth of the 
cell population the mutation occurred. For instance, if it occurred early in time, the 
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mutation will be represented in more cells and have a higher frequency in the total 
population than if it occurred later in the growth of the population (the population here 
may be the total cells of an organ). This issue is further complicated when we consider 
that the mutation may cause a growth (dis)advantage relative to other cells in the 
population, or that cell division rates and/or survival may change as a function of age.  
Thus, in order to determine whether there is a difference in LOH in young and old 
organisms, it is critical to determine mutation rate. This quantitative information can then 
provide insight about qualitative changes that occur in an age-dependent manner in 
particular biological process(es).  
In the human lymphocyte studies the authors attempt to address the issue of clonal 
expansion by identifying clones among the mutants through analysis of the T-cell 
Receptor (TCR) β-chain, or by sequence analysis of the mutations among the clonally 
expanded cells (Morley et al., 1990). Mutant cells that carry identical TCR 
rearrangements are considered events from a single clone and are not included within the 
frequency calculations. Nevertheless, at best, this places an upper limit on the frequency 
value.  
Each of the studies above contrasts cells from a young donor to those of an old 
donor.  However, it has been shown that there is a significant variation in the mutation 
frequency among individuals of similar age (Gupta et al., 1997). Thus it would be ideal to 
carry out repeated sampling from an individual over time, to provide a better control for 
age-induced change. Clearly, such an experiment has inherent limitations with human 
subjects.  
Addressing The Issues 
 An assay was designed in budding yeast to measure the rate of LOH with 
increasing age, and thus addresses several of these unresolved issues (McMurray and 
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Gottschling, 2003).  The budding yeast, Saccharomyces cerevisiae, is a model organism 
tractable to studies of age-induced LOH, in part because it undergoes asymmetric 
division; a yeast mother cell gives rise to developmentally distinct daughter cells for a 
number of divisions until the mother cell has reached a full replicative lifespan. To 
determine the replicative lifespan of a budding yeast cell, micromanipulation is used to 
dissect each daughter away from the mother until she undergoes senescence.  Previous 
studies have used micromanipulation to ask the question: Does the rate of LOH change 
with increasing age (McMurray and Gottschling, 2003)?  Through the course of a mother 
cell’s replicative lifespan each daughter cell was removed and allowed to form individual 
colonies.  In this way, each cell division of the mother is accounted for by analysis of the 
daughter colonies.  These colonies were then scored for LOH by the use of color markers.  
As the mothers aged, an increase in the rate of LOH occurred in her progeny.  The 
finding of increased LOH in the progeny of old cells provided the first direct evidence 
that the rate of genomic instability changes with age.   
Other investigators have detected an increase in frequency of mutations in 
populations of “non-dividing” yeast over time (Madia et al., 2007).  Although these 
observations have been interpreted as evidence for an increased mutation frequency in 
post-mitotic cells, it also possible there was a selection for cells that entered the non-
dividing state with mutations. During the course of this “chronological aging” there is a 
dramatic reduction in cell viability within the population – thus putting enormous 
selective pressure for cells with mutations; such a scenario has been documented in 
bacterial cells (Roth et al., 2006).  
3.  Does the Ability to Repair DNA Damage Diminish with Age?  
If we accept the premise that there is an age-dependent increase in LOH, then 
how does this occur? There are two routes by which an increase could arise: more DSB 
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DNA damage and/or a change in the repair of DNA damage. Unfortunately, methods to 
directly measure DNA damage in the form of DSBs are notoriously insensitive and while 
surrogate markers (modified or localized repair proteins) are available, they are difficult 
to accurately quantify (reviewed in Takahashi and Ohnishi, 2005). Furthermore, even 
with accurate quantification of DSBs, it would be unclear whether an increase in DSBs 
was the result of more intrinsic DNA damage or a failure to accurately repair normal 
levels of damage. Consequently, there has been a greater focus on asking whether a cell 
has the capacity to effectively repair DNA damage. For instance, studies of cultured 
fibroblasts and lymphoblasts, from human donors of different ages, revealed a decreased 
capacity to repair UV induced DNA damage in old cells (Goukassian et al., 2000; 
Moriwaki et al., 1996).  
The Experimental Data 
 Building on the observations of these earlier studies, the ability of old cells to 
repair DSBs has been analyzed.  Normal human fibroblasts were assessed for 
circularization of a transfected linear plasmid (Seluanov et al., 2004). With this plasmid 
rejoining assay, it was found that young fibroblasts were more efficient at non-
homologous end joining (NHEJ) than cells which had been passaged multiple times 
(presenescent cells) or that had ceased dividing (senescent cells).  In addition, DNA 
repair in the senescent cells was more error-prone in that larger deletions of nucleotides 
were seen at the repair site.  Of note, the authors also used the same cell lines transfected 
with the catalytic component of the human telomerase to create immortalized cells lines.  
These cells were considered young, despite undergoing over 100 population doublings (at 
least 30 more than the normal fibroblast senescent cells) because they had not yet stopped 
proliferating.  There was no change in efficiency of NHEJ in the immortalized, non-
senescent cells compared to the young cells of the wild-type cell line.  The authors 
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conclude that the changes in efficiency and fidelity of DSB repair by NHEJ were a 
function of cellular senescence and not the replicative age of these cells.    
Unresolved Issues 
This work provides direct evidence for a change in the ability to repair DSBs in 
senescent cells, and provides a good start for determining what changes may occur in 
DNA repair as cells senesce (Seluanov et al., 2004). However, it is also important to 
detect other forms of DSB repair, particularly homologous recombination (HR).  NHEJ 
and HR are likely to be in competition for DSB substrates, so a reduction in NHEJ 
activity may lead to an increase use of homologous recombination pathways, which can 
increase the amount of LOH along an affected chromosome (see Figure 1).  
While the plasmid rejoining assay has shown robust difference between senescent 
and young cells, it is based upon transfection of naked DNA template into cells. However 
DSBs that arise in old cells are not within naked DNA, but in the presence of chromatin. 
Because modifications to chromatin at the DNA break site have been found to play a role 
in DSB repair (Morrison et al., 2004), an assay which analyzes repair of an integrated cut 
site, or spontaneous DSB, may ultimately be needed to assess what changes are most 
relevant in aging cells (Haber, 2002).  
This set of experiments also highlights another important issue in aging-related 
studies of DNA repair (and aging studies in general) – defining what an ‘old cell’ is.  Are 
old cells those that have undergone multiple cellular divisions, those that have been 
collected from a donor of advanced chronological age?  In studies of cells collected from 
donors of advanced age, is there a significant difference between post-mitotic cells, those 
that can be further expanded in vitro (such as lymphocytes), and germ cells?  This 
question becomes important in studies where discrepancies are noted between the repair 
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capacity of these different ‘old’ cells.  This issue is also relevant when drawing 
conclusions from various model organisms. 
4.  Does the Method of DNA Repair Change with Age? 
Although eukaryotic cells predominantly use NHEJ and HR to resolve DSBs, 
each of these categories, particularly HR, can be further divided into distinct repair 
pathways.  During HR a template provides the missing DNA sequence information for 
DSB repair.  The cell can use the sister chromatid as the template (sister chromatid 
exchange), or the homologous chromosome (e.g. gene-conversion or crossing-over).  The 
length of the homologous tract can also vary.  For example, in break-induced replication 
(BIR) the tract extends from the break site all the way to the chromosome end. Because 
each type of repair results in different changes to the broken chromosome, the type of 
repair used to resolve a DSB can lead to different amounts of LOH (Figure 1).  For 
example, there is no LOH when a DSB is repaired via sister chromatid exchange, while  
BIR produces a large segment of LOH within the repaired chromosome. 
 Numerous factors influence the choice of repair method, including the stage of the 
cell cycle.  For example, sister chromatid exchange cannot take place in G1 (there is no 
sister chromatid). In fact, homologous recombination appears to be repressed in G1 
(Fishman-Lobell et al., 1992) and NHEJ is preferentially used in this stage of the cell 
cycle (Aylon and Kupiec, 2005). Cell-type specific regulation of the DNA damage repair 
method has also been demonstrated.  For example haploid yeast exert mating type control 
of NHEJ (Frank-Vaillant and Marcand, 2001). In addition alternative pathways for DSB 
repair can effectively compete with one another at the same break site (Fishman-Lobell et 
al., 1992; Tutt et al., 2001).  As shown in budding yeast and cultured mammalian cell 
lines, if one repair pathway within a cell is compromised, whether due to the conditions 
of the DSB or dysfunction in components of the pathway, other repair pathways are able 
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to compete for the DNA substrate and change the predominate form of repair used.  As 
this can change the amount of LOH seen in the repaired chromosome, it is important to 
understand how advanced age affects which repair mechanism is used at a DSB. 
The Experimental Data 
The work described previously, in which budding yeast were analyzed for age-
induced LOH, revealed not only an increase of LOH in the progeny as the mother cell 
aged, but also a change in the type of repair (McMurray and Gottschling, 2003).  
Specifically, old mothers predominantly used BIR, a change from crossing over that is 
normally seen in young cells.  Thus both qualitative and quantitative changes are 
manifested in LOH as yeast cells age.  
Studies in Drosophila have also identified a change in the method of DSB repair, 
in the germ cells of aging males (Preston et al., 2006).  In this study a DSB was induced 
within a reporter construct in premeiotic, male germ cells.  The males were mated with 
different virgin females each week throughout the male’s life, and the DNA in the 
resulting progeny were examined for how the DSB was repaired. As the males aged, 
there was a switch from predominantly NHEJ to predominantly HR repair. In addition, 
the length of the homologous recombination tract was longer in the progeny of old than 
in young male flies.  Thus once again, cells of advanced age appeared to have a change in 
the primary DNA repair pathway; this change resulted in increased amounts of LOH.   
Unresolved Issues 
Although these studies provide new evidence for an influence of age on LOH, 
they also have experimental limitations. While micromanipulation of the daughters of 
aging yeast allows each division of the aging mother cell to be followed, LOH can only 
be analyzed in the progeny with this assay (McMurray and Gottschling, 2003).  In this 
way the genomic instability of the progeny is a surrogate for analysis of the effect of 
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aging on the mother’s genome.  Ultimately, the analysis of chromosomes and DNA 
damage repair within the aging mother cell is necessary for a better understanding of how 
this change is manifested.  
The analysis of LOH with aging Drosophila also has limitations (Preston et al., 
2006).  The authors were not able to assess whether changes in LOH were associated 
with changes in cell death, decreased viability or reduced fertility of sperm, thus making 
it difficult to draw conclusions about the overall efficiency of repair.  Also, will these 
findings from germ cells be relevant to what happens in somatic cells? Regardless, this 
study represents the most direct evidence concerning a change in DNA repair with age.  
5.  Conclusions 
Although studies of mammalian cells consistently reveal an increased frequency 
of mutations with advanced age, the experimental data to date do not clearly demonstrate 
an age-dependent change in the rate of LOH in vivo.  However evidence from non-
mammalian model organisms has provided some of the first evidence that the rate of 
LOH does indeed increase with age.  Several studies demonstrate an overall functional 
decline in different types of DNA repair with age.  Perhaps the most interesting finding in 
the studies of age-induced LOH, is the evidence for a change in the mechanism of repair 
used to resolve a DSB in an old cell.  To date this has been demonstrated in two model 
organisms, S. cerevisiae and Drosophila.  In both studies the change in repair has led to 
increased amounts of LOH at the repair site.  Thus the amount of DNA damage and 
capacity for repair may ultimately be less important than the repair mechanism used 
when considering the amount of genomic material which has been altered.  
 Previous work in young cells has demonstrated that different repair pathways can 
compete for the same DNA lesion (Fishman-Lobell et al., 1992).  In effect the DNA end 
produced at a DSB site is a substrate for which various DNA repair proteins compete.  
13 
There is evidence that a change in the kinetics of one pathway or a functional decline in 
the proteins of another can alter the outcome for this substrate.  Protein oxidation is 
known to increase with age, and can lead to protein dysfunction (Stadtman, 1992). In 
addition oxidative modification does not affect the proteome uniformly, in that some 
proteins are more prevalent targets (Cabiscol et al., 2000).  In studies of budding yeast, 
carbonylated proteins were visualized in single cells and seen to accumulate with 
increased replicative age (Aguilaniu et al., 2003).  Thus protein modifications due to 
oxidative damage may alter the balance of functional repair proteins present at a DSB and 
ultimately affect the changes to the broken chromosome after repair.   
In summary, our understanding of age-induced changes to LOH remains 
incomplete, but recent studies have provided exciting new information on this process. It 
will be important to understand the full dynamic process of DSB repair in real time to 
understand the affect of aging on the capacity of old cells to resolve DSBs. For instance, 
are proteins involved in DSB repair prone to age-related damage, and if so, how might 
this affect their function and expression levels?  Ultimately if we are to understand the 
affect of aging on LOH, we must understand how a DSB arises and is handled in old 
cells.   Fortunately, our knowledge of age-induced LOH is increasing.  
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 Figure 1. How a Double-Strand Break leads to LOH.   
A spontaneous double-strand break that occurs following DNA replication (S/G2 
in the cell cycle), results in different amounts of LOH depending on how repair occurs. A 
schematic version of two homologous chromosomes is presented – one red, one blue. 
Each chromosome is replicated and one of the sister chromatids (#2) receives a double 
strand break. The repair process is initiated and the chromatids are segregated (odd 
numbered chromatids in one cell and evens in the other).  
Truncation occurs when the broken chromosome is capped with a telomere at or 
near the break site.  Chromosome Loss will occur if the lack of effective repair leads to 
non-disjunction of the affected chromosome. (This may also occur without a DSB – e.g. 
when there are defects in the mitotic apparatus.) Non-Homologous End Joining (NHEJ) 
may lead to a small local deletion following resection and ligation of the DSB.  
Recombination mediated mechanisms, such as Gene Conversion result in loss of the 
affected allele as it is replaced with a copy of the homologous allele.  Break-Induced 
Replication results in LOH by recombination initiated replication from the DSB to the 
end of the chromosome.  Finally, a homologous recombination event may include a 
Crossover that leads to reciprocal exchange of genetic information and LOH in both 
cells after division. 
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